The FDA has banned all of the products made by an Indian drugmaker as it investigates an outbreak of dozens of hospital infections. 

Pfizer’s stop-smoking drug Chantix may be one step closer to escaping the FDA’s black box. An agency advisory panel narrowly voted in favor of removing the FDA…

Congress is starting to get some answers on EpiPen pricing. And though, so far, Mylan’s not offering much beyond what’s readily available via Google search,…

Generic drug prices in Medicare Part D decreased significantly in recent years. So why the worry about price hikes? "Extraordinary" increases on…

Pfizer CEO Ian Read called Hillary Clinton's plan to curb drug prices "very negative for innovation."

Biogen rolled out its Remicade biosimilar in the U.K., thus becoming the first drugmaker to market two anti-TNF biosims there. But don't expect anyone to…

Merck & Co. is officially on its way to eclipsing BMS in lung cancer. Its immuno-oncology drug Keytruda won a breakthrough tag for first-line treatment, a…

Government warns drugmakers could leave the UK if the country's separation from the EU drags on and is kept under wraps.